Cardiology

Even the most seasoned medical research teams can find themselves not reaching the goals they set out for themselves in a study. Learning from those lessons can sometimes be more motivation to find answers down the road.

With statins being a common treatment option for high cholesterol and PCSK9 inhibitors gaining traction since their approval in the past year research has looked at just how low a person's LDL, or bad cholesterol can go.

At the 2015 meeting of the American College of Cardiology PCSK9 inhibitors like Praluent were moving closer to approval but were not there yet. Since then they have been approved and begun to be introduced to the public.

An honest follow-up story to something we are all in danger of facing, burnout, and why it's so easy to find yourself back at the point of no return

Heart patients will soon have access to a new pacemaker without wired leads.

The American College of Cardiology's outgoing President Kim A. Williams, MD, went vegan in 2003 and never looked back. He talks about the diet's power to heal and how being the ACC's first vegan leader played out.

Vitamin D has long been touted for its several health benefits.

How a doctor presents themselves on social media can determine how effective it is in getting their message across while also maintaining a safe barrier between them and their patients.

Social media platforms like Facebook and Twitter may be regularly used by patients but some doctors have been slower to incorporate these tools into their practice.

As Xarelto is used in practice by more doctors researchers at Janssen Pharmaceuticals are getting a better sense of its efficacy beyond the extensive clinical trials it underwent.

As one of the components of the CHADS2 score diabetes is a known risk for stroke. A recent study looked at how rivaroxaban, also known as Xarelto can help patients reduce this potentially deadly health issue.

An electronic device that stimulates the vagus nerve improved patients’ ability to walk farther without getting winded and was proven to be safe, but it did not affect rates of death or hospitalization, researchers found.

Stem cell treatment did 37% better than placebo treatment in a group of patients with ischemic heart failure.

Adding aliskiren to enalapril in treating heart failure patients resulted in more adverse events but no benefit, a UK team reported.

When you become a doctor, it’s no secret that you will have to deal with people all day long. And, in the course of these many human interactions (sometimes under stressful circumstances), there are bound to be some awkward, uncomfortable and painfully silent moments.

Only a handful of medications carry an FDA indication for obesity, but metformin (which currently does not) has weighty evidence supporting its use.

Animal studies have shown melatonin reduces body weight, plasma leptin, adiponectin, triglycerides, cholesterol, insulin, and glucose levels beyond its effects on circadian rhythm.

Low-dose weekly chloroquine is lipid modulating, although to a smaller extent than high-dose therapy. Study results suggest that low-dose chloroquine is an inexpensive and well-tolerated agent for dyslipidemia patients.

For those how enter the field of genetic testing there are many challenges along the way, starting with finding the right training program through using that training in very difficult situations.

As more is learned about genetic conditions in cardiology more is being done to help not only to help the patients themselves but those around them as well.

What once began in slow motion is now rapidly accelerating. The house of medicine is on fire, not with passionate purpose, but with a majority of doctors who are burning out.

Hopes that losmapimod would benefit patients after a STEMI heart attack were not borne out by a study reported today at the American College of Cardiology's meeting in Chicago, IL.

The search for a drug to prevent kidney injuries from contrast media used in coronary angiography goes on. Trials of a new drug were disappointing.

Treating atrial fibrillation by ablation is equally effective whether done by freezing or burning small parts of the heart.

In the real world, which patients get P2Y inhibitors? A Mount Sinai team investigated.

A newer version of a valve system used in transcatheter aortic valve replacement has proved superior to surgery in elderly patients. The study was released a day after a report on the older device showed it was as good as surgery.

A large genetic analysis showed that the incidence of a single genetic mutation in familial hypercholesterolemia patients is smaller than thought--but that those who do have the mutation face a far higher risk of heart disease.

Reportingg on a trial known as ACCELERATE, researchers said a powerful CETP inhibitor did not reduce cardiovascular events, despite having “Profound HDL-C raising and LDL-C lowering propertie

There were hundreds of presentations on high-tech innovations and the latest drugs for heart disease. But unless cardiologists find better ways to prevent cardiovascular illness, deaths will keep rising, the ACC's Kim Williams, MD said in his welcome speech.

When patients are statin-intolerant but have high cholesterol, physicians have other options, a Cleveland Clinic study finds.